Literature DB >> 7959501

[Magnesium in migraine. Results of a multicenter pilot study].

K Taubert1.   

Abstract

BACKGROUND: Numerous experiments and clinical observations have credited magnesium with a positive influence on the incidence of migraine attacks.
METHODS: With the aim of testing this hypothesis, a doubleblind, cross-over multicenter pilot study was initiated. The study contained 43 migraine patients who met the criteria of the international Headache Society.
INTERVENTIONS: Administration of 600 mg magnesium/day in the form of trimagnesium dieitrate for prophylaxis.
RESULTS: Under this medication, a significant reduction in the incidence of migraine attacks was observed. Although the level of effectiveness of the regimen does not appear to be as high as that of presently approved migraine prophylactic substances, a very low rate of side effects can be expected.
CONCLUSION: The working hypothesis to the effect that magnesium may be useful in the prevention of migraine attacks has been confirmed by the pilot study. Further studies aimed at determining dosage and enabling a further differentiation of patient material are in preparation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959501

Source DB:  PubMed          Journal:  Fortschr Med        ISSN: 0015-8178


  5 in total

1.  Should magnesium be given to every migraineur? No.

Authors:  Arpad Pardutz; Laszlo Vecsei
Journal:  J Neural Transm (Vienna)       Date:  2012-03-18       Impact factor: 3.575

Review 2.  Magnesium and Pain.

Authors:  Hyun-Jung Shin; Hyo-Seok Na; Sang-Hwan Do
Journal:  Nutrients       Date:  2020-07-23       Impact factor: 5.717

3.  Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.

Authors:  Charly Gaul; Hans-Christoph Diener; Ulrich Danesch
Journal:  J Headache Pain       Date:  2015-04-03       Impact factor: 7.277

Review 4.  Non-Pharmacological Approaches for Migraine.

Authors:  Francesca Puledda; Kevin Shields
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 5.  Headaches and Magnesium: Mechanisms, Bioavailability, Therapeutic Efficacy and Potential Advantage of Magnesium Pidolate.

Authors:  Jeanette A Maier; Gisele Pickering; Elena Giacomoni; Alessandra Cazzaniga; Paolo Pellegrino
Journal:  Nutrients       Date:  2020-08-31       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.